Living systematic review and meta-analysis of MDMA-assisted therapy trials for PTSD
A living systematic review, meta-analysis, and open data resource of trials of MDMA-assisted therapy for PTSD
The authors report a living systematic reviewsystematic reviewA review that uses a stated, repeatable method to find and assess all the studies on a question.Open the glossary and meta-analysismeta-analysisA statistical method that combines the results of several studies into one estimate.Open the glossary of six randomised controlled trialsRCTA randomised controlled trial, in which participants are assigned by chance to the treatment being tested or to a comparison.Open the glossary of MDMA-assisted therapy for post-traumatic stress disorderPTSDPost-traumatic stress disorder, a mental health condition that can follow exposure to a traumatic event.Open the glossary (PTSD), all using the MAPS protocol, finding a pooled Hedges' g of -0.71 [-0.95; -0.47], p < 0.001, k = 6, n = 242.
The review pools only six MAPS-sponsored trials and rates the evidence low certainty, so readers can see how much of the headline effect rests on one sponsor's therapy model.
Key facts
- Compound
- MDMA
- Condition
- PTSD
- Jurisdiction
- United States
- Source
- Neuropsychopharmacology (psychedelics only) (nature.com)
- Published
- Original
- Read it at nature.com
How this summary was made
The summary and the “Why it matters” note were written by an AI model from the linked source, and a model scored the item against this site's editorial criteria. The facts above come from the item's topics and from identifiers written out in the stored text. Anything not found there is left out, so a missing row means not stated, not no. Read the original before relying on any detail. Editorial method
Source: Neuropsychopharmacology (psychedelics only) · nature.com
Connected to
- Compound
- MDMA
- Condition
- PTSD
- Jurisdiction
- United States